Drug screen negative
(UMLS:C0919819)
- UMLS ID:
- C0919819
- MeSH ID:
- N/A
Synonym(s)
1.
Drug screen negative
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fentanyl | FAERS: 73 | US FAERS | |
| 2 | Clonazepam | FAERS: 57 | US FAERS | |
| 3 | Oxymorphone | FAERS: 37 | US FAERS | |
| 4 | Buprenorphine | FAERS: 33 | OFFSIDES US FAERS | |
| 5 | Methylphenidate | FAERS: 24 | US FAERS | |
| 6 | Lorcet | FAERS: 18 | US FAERS | |
| 7 | Oxycodone | FAERS: 12 | US FAERS | |
| 8 | Lisdexamfetamine Dimesylate | FAERS: 11 | US FAERS | |
| 9 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 10 | US FAERS | |
| 10 | Methylphenidate | FAERS: 9 | US FAERS | |
| 11 | Alprazolam | FAERS: 8 | US FAERS | |
| 12 | Hydromorphone | FAERS: 8 | US FAERS | |
| 13 | Oxymorphone | FAERS: 8 | US FAERS | |
| 14 | Lorazepam | FAERS: 7 | US FAERS | |
| 15 | Morphine | FAERS: 6 | US FAERS | |
| 16 | Oxycodone and acetaminophen | FAERS: 6 | US FAERS | |
| 17 | Buprenorphine | FAERS: 5 | US FAERS | |
| 18 | Methadone | FAERS: 5 | OFFSIDES US FAERS | |
| 19 | Tapentadol | FAERS: 5 | US FAERS | |
| 20 | Naltrexone | FAERS: 3 | US FAERS | |
| 21 | Ranitidine | FAERS: 3 | US FAERS | |
| 22 | Tapentadol | FAERS: 3 | US FAERS | |
| 23 | Acetaminophen | FAERS: 2 | US FAERS | |
| 24 | Adderall | FAERS: 2 | US FAERS | |
| 25 | Asenapine | FAERS: 2 | US FAERS | |
| 26 | Desvenlafaxine Succinate | FAERS: 2 | US FAERS | |
| 27 | Diazepam | FAERS: 2 | US FAERS | |
| 28 | Guaifenesin | FAERS: 2 | US FAERS | |
| 29 | Meperidine | FAERS: 2 | US FAERS | |
| 30 | Methadone | FAERS: 2 | US FAERS | |
| 31 | Methylphenidate | FAERS: 2 | US FAERS | |
| 32 | Ranitidine | FAERS: 2 | US FAERS | |
| 33 | amitriptyline, chlordiazepoxide drug combination | FAERS: 2 | US FAERS | |
| 34 | dolutegravir | FAERS: 2 | US FAERS | |
| 35 | 1-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chloride | FAERS: 1 | US FAERS | |
| 36 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 37 | Buprenorphine, Naloxone Drug Combination | FAERS: 1 | US FAERS | |
| 38 | Carboplatin | FAERS: 1 | US FAERS | |
| 39 | Carisoprodol | FAERS: 1 | US FAERS | |
| 40 | Clozapine | FAERS: 1 | US FAERS | |
| 41 | Cyclosporine | FAERS: 1 | US FAERS | |
| 42 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 43 | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | FAERS: 1 | US FAERS | |
| 44 | Eszopiclone | FAERS: 1 | US FAERS | |
| 45 | Gabapentin | FAERS: 1 | US FAERS | |
| 46 | Hydrochlorothiazide | FAERS: 1 | US FAERS | |
| 47 | Ibuprofen | FAERS: 1 | US FAERS | |
| 48 | Lisinopril | FAERS: 1 | US FAERS | |
| 49 | Mycophenolic Acid | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Naproxen | FAERS: 1 | US FAERS | |
| 51 | NuvaRing | FAERS: 1 | US FAERS | |
| 52 | Phentermine | FAERS: 1 | US FAERS | |
| 53 | Risperidone | FAERS: 1 | US FAERS | |
| 54 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 55 | Temazepam | FAERS: 1 | US FAERS | |
| 56 | Thyroxine | FAERS: 1 | US FAERS | |
| 57 | Tramadol | FAERS: 1 | US FAERS | |
| 58 | Tramadol | FAERS: 1 | US FAERS | |
| 59 | Warfarin | FAERS: 1 | US FAERS | |
| 60 | Zolpidem | FAERS: 1 | US FAERS | |
| 61 | Zolpidem | FAERS: 1 | US FAERS | |
| 62 | ceftolozane, tazobactam drug combination | FAERS: 1 | US FAERS | |
| 63 | linaclotide | FAERS: 1 | US FAERS | |
| 64 | posaconazole | FAERS: 1 | US FAERS | |
| 65 | Carbidopa | OFFSIDES | ||
| 66 | Docusate sodium | OFFSIDES | ||
| 67 | Doxepin | OFFSIDES | ||
| 68 | Etodolac | OFFSIDES | ||
| 69 | Flurazepam | OFFSIDES | ||
| 70 | Solifenacin Succinate | OFFSIDES | ||
| 71 | chlordiazepoxide, clidinium drug combination | OFFSIDES | ||
| 72 | tizanidine | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.